LIVZON PHARMAC. GRP H YC1 (LP6) — Defensive Interval Ratio
LIVZON PHARMAC. GRP H YC1 (LP6) has a Defensive Interval Ratio of 133 days as of March 2026. Defensive assets of €2.91 Billion (cash €-, short-term investments €707.99 Million, receivables €2.20 Billion) cover 133 days of daily cash needs of €21.88 Million/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
LIVZON PHARMAC. GRP H YC1 Defensive Interval Ratio (2021–2025)
This chart shows how LIVZON PHARMAC. GRP H YC1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 133 days, meaning defensive assets of €2.91 Billion can fund 133 days of operations without new revenue. For the complete balance sheet picture, see LP6 current and non-current assets.
Annual Defensive Interval Ratio for LIVZON PHARMAC. GRP H YC1 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for LIVZON PHARMAC. GRP H YC1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See LIVZON PHARMAC. GRP H YC1 current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 182 days | €3.59 Billion | €19.78 Million/day | €- | €1.34 Billion | ▲ +85 days |
| 2024 | 97 days | €2.02 Billion | €20.89 Million/day | €- | €89.36 Million | ▼ -2 days |
| 2023 | 99 days | €2.20 Billion | €22.16 Million/day | €- | €81.79 Million | ▼ -25 days |
| 2022 | 125 days | €2.52 Billion | €20.26 Million/day | €- | €108.09 Million | ▲ +12 days |
| 2021 | 113 days | €2.13 Billion | €18.97 Million/day | €- | €182.77 Million | — |